[go: up one dir, main page]

WO2008018639A3 - Inhibiteur de transporteurs de glycine - Google Patents

Inhibiteur de transporteurs de glycine Download PDF

Info

Publication number
WO2008018639A3
WO2008018639A3 PCT/JP2007/065988 JP2007065988W WO2008018639A3 WO 2008018639 A3 WO2008018639 A3 WO 2008018639A3 JP 2007065988 W JP2007065988 W JP 2007065988W WO 2008018639 A3 WO2008018639 A3 WO 2008018639A3
Authority
WO
WIPO (PCT)
Prior art keywords
disorder
compound
anxiety
glycine transporter
transporter inhibitor
Prior art date
Application number
PCT/JP2007/065988
Other languages
English (en)
Other versions
WO2008018639A2 (fr
Inventor
Yoshinori Sekiguchi
Taketoshi Okubo
Tsuyoshi Shibata
Kumi Abe
Shuji Yamamoto
Shuhei Kashiwa
Original Assignee
Taisho Pharmaceutical Co Ltd
Yoshinori Sekiguchi
Taketoshi Okubo
Tsuyoshi Shibata
Kumi Abe
Shuji Yamamoto
Shuhei Kashiwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Yoshinori Sekiguchi, Taketoshi Okubo, Tsuyoshi Shibata, Kumi Abe, Shuji Yamamoto, Shuhei Kashiwa filed Critical Taisho Pharmaceutical Co Ltd
Publication of WO2008018639A2 publication Critical patent/WO2008018639A2/fr
Publication of WO2008018639A3 publication Critical patent/WO2008018639A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
    • A47J27/00—Cooking-vessels
    • A47J27/002—Construction of cooking-vessels; Methods or processes of manufacturing specially adapted for cooking-vessels
    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
    • A47J36/00—Parts, details or accessories of cooking-vessels
    • A47J36/02—Selection of specific materials, e.g. heavy bottoms with copper inlay or with insulating inlay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Manufacturing & Machinery (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne un composé représenté par la formule (I) ou un sel pharmaceutiquement acceptable de ce composé, ou un hydrate de ce composé ou de son sel, servant à la prévention ou au traitement de maladies telles que la schizophrénie, la maladie d'Alzheimer, le dysfonctionnement cognitif, la démence, les troubles de l'anxiété (état d'anxiété généralisé, état de panique, trouble obsessionnel compulsif, état d'anxiété social, état de stress post-traumatique, phobies particulières, état de stress grave etc.), la dépression, l'abus de drogues, les convulsions, les tremblements et les troubles du sommeil, sur la base de l'effet d'inhibition de l'absorption de glycine.
PCT/JP2007/065988 2006-08-11 2007-08-10 Inhibiteur de transporteurs de glycine WO2008018639A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006220267A JP2009179562A (ja) 2006-08-11 2006-08-11 グリシントランスポーター阻害剤
JP2006-220267 2006-08-11

Publications (2)

Publication Number Publication Date
WO2008018639A2 WO2008018639A2 (fr) 2008-02-14
WO2008018639A3 true WO2008018639A3 (fr) 2008-04-03

Family

ID=39033397

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/065988 WO2008018639A2 (fr) 2006-08-11 2007-08-10 Inhibiteur de transporteurs de glycine

Country Status (3)

Country Link
JP (1) JP2009179562A (fr)
AR (1) AR062325A1 (fr)
WO (1) WO2008018639A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR075182A1 (es) * 2009-01-28 2011-03-16 Astrazeneca Ab Compuestos 2-aza-biciclo (2.2.2) octano y sus usos
CN102405222A (zh) * 2009-01-28 2012-04-04 阿斯利康(瑞典)有限公司 2-氮杂-二环[2.2.1]庚烷化合物及其用途
FR2943056A1 (fr) * 2009-03-16 2010-09-17 Sanofi Aventis Derives de n-°2-aza-bicyclo°2.1.1!hex-1-yl)-aryl-methyl!- heterobenzamide, leur preparation et leur application en therapeutique
RU2011141778A (ru) * 2009-03-16 2013-04-27 Санофи Производные n-[(2-азабицикло[2.1.1]гекс-1-ил)арилметил]гетеробензамида, их получение и их применение в терапии
TW201247647A (en) * 2011-02-21 2012-12-01 Taisho Pharmaceutical Co Ltd Glycine transport inhibitor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003089411A1 (fr) * 2002-04-19 2003-10-30 Sanofi-Aventis Derives de n-[phenyl(piperidin-2-yl)methyl] benzamide, leur preparation et leur application en therapeutique
WO2006134341A1 (fr) * 2005-06-13 2006-12-21 Merck Sharp & Dohme Limited Agents therapeutiques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003089411A1 (fr) * 2002-04-19 2003-10-30 Sanofi-Aventis Derives de n-[phenyl(piperidin-2-yl)methyl] benzamide, leur preparation et leur application en therapeutique
WO2006134341A1 (fr) * 2005-06-13 2006-12-21 Merck Sharp & Dohme Limited Agents therapeutiques

Also Published As

Publication number Publication date
AR062325A1 (es) 2008-10-29
JP2009179562A (ja) 2009-08-13
WO2008018639A2 (fr) 2008-02-14

Similar Documents

Publication Publication Date Title
WO2009064388A3 (fr) Inhibiteurs de la méthionine aminopeptidase humaine 1 et procédés de traitement de troubles
WO2007136759A3 (fr) Procédé de traitement et de prévention de troubles oculaires
WO2007143600A3 (fr) Inhibiteurs de la sheddase combinés avec des substances immunothérapeutiques se liant à cd30 destinés au traitement de maladies associées à cd30
WO2006121560A3 (fr) Procedes et compositions pour le traitement des pathologies associees au systeme nerveux central
WO2007127505A3 (fr) Composés chimiques
WO2006023544A3 (fr) Applications therapeutiques d'inhibiteurs de rtp801
WO2006113942A3 (fr) Procede d'inhibition de l'activite de cathepsine
WO2007062999A3 (fr) Derives de indole-2-yl amide substitues en 1,5
EP2977452A3 (fr) Procédés de traitement et de prévention de maladies et de troubles neurodégénératifs
WO2007112014A3 (fr) Nouvelles combinaisons thérapeutiques pour le traitement de la dépression
EP2604602A4 (fr) Dérivé d'hétéroaryl pyrazole
WO2005089753A3 (fr) Benzisoxazoles
WO2008079873A3 (fr) Utilisation de composés thiazolyle comme inhibiteurs de kinases
WO2008018639A3 (fr) Inhibiteur de transporteurs de glycine
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
EA200700909A1 (ru) Азаиндолкарбоксамиды
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
DK1670903T3 (da) Behandling af neurodegenerative sygdomme
MX2009005351A (es) Compuestos utiles para tratar trastornos neurodegenerativos.
WO2006036928A3 (fr) Inhibiteurs de metalloproteinases matricielles pour traiter des troubles neurologiques
WO2009015369A3 (fr) Composés qui inhibent l'activité de la bêta-sécrétase et procédés d'utilisation de ceux-ci
WO2007129221A8 (fr) Compositions et méthodes destinées au traitement de troubles liés à l'agrégation des protéines
MX2010002765A (es) Derivado de 6-pirimidinil-pirimid-4-ona.
WO2007034329A3 (fr) Composes et procedes pour le traitement de troubles lies au peptide beta-amyloide
WO2007034326A3 (fr) Composes imidazoles pour le traitement de troubles neurologiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07805937

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 07805937

Country of ref document: EP

Kind code of ref document: A2